Home > Riviste > International Angiology > Fascicoli precedenti > Articles online first > International Angiology 2021 Nov 09

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi PROMO
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

 

International Angiology 2021 Nov 09

DOI: 10.23736/S0392-9590.21.04704-0

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

Mortality and bleeding complications of COVID-19 critically ill patients with venous thromboembolism

Daniel GIL-SALA 1, 2, Claudia RIERA 3, Marvin GARCÍA-REYES 1, 2 , Manuela RODRÍGUEZ 3, Carlos E. MARRERO 1, 2, Lucía MARTÍNEZ 3, Miquel GIL 3, Juan Carlos RUIZ-RODRÍGUEZ 4, Ricard FERRER 4, Miriam DE NADAL 5, Milagros A. SUITO-ALCÁNTARA 6, Secundino LLAGOSTERA 3, Sergi BELLMUNT 1, 2

1 Angiology and Vascular Surgery Department, Hospital Universitari Vall d’Hebron, Barcelona, Spain; 2 Department de Cirurgia, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain; 3 Angiology and Vascular Surgery Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; 4 Intensive Care Department, Hospital Universitari Vall d’Hebron, Barcelona, Spain; 5 Anesthesiology, Hospital Universitari Vall d’Hebron, Barcelona, Spain; 6 Hemostasis Unit, Hematology Department, Hospital Universitari Vall d’Hebron, Barcelona, Spain


PDF


BACKGROUND: VTE disease in COVID-19 patients is a remarkable issue, especially its relationship with bleeding events and mortality. The objective of this study was to describe the outcomes of critically ill patients with COVID-19 hospitalized in ICU in relationship with VTE during their stay.
METHODS: Prospective cohort study of critically ill COVID-19 patients in two hospitals that underwent a venous ultrasound at the beginning of follow-up of both lower limbs in April 2020. When clinical suspicion of new VTE during the 30-day follow-up, additional ultrasound or thoracic CT were performed. Global VTE frequency, major bleeding events and survival were collected, and their predictors were studied.
RESULTS: We included 230 patients. After 30 days of follow-up, there were 95 VTE events in 86 patients (37,4%). 13 patients (5,7%) developed major bleeding complications and 42 patients (18,3%) died. None of the comorbidities or previous treatments were related with bleeding events. D-dimer at admission was significantly related with VTE development and mortality. Independent predictors of mortality in the regression model were an older age (>66 years), D-dimer at admission (>1 500ng/mL) and low lymphocyte count (<0,45x109/L) with an AUC in the ROC curve of 0,81 (95%CI: 0,73-0,89). Patients presenting these three conditions presented a mortality of a 100% in the predictive model.
CONCLUSIONS: VTE frequency in ICU COVID-19 patients is high and risk of major bleeding is low. Comorbidities and laboratory parameters of admission in these patients can be a useful tool to predict mortality.


KEY WORDS: SARS-CoV-2 infection; COVID19; Venous thromboembolism; Deep venous thrombosis; Mortality; Bleeding

inizio pagina